source
- Tango and Revolution report high response rates in early pancreatic cancer combo trialTango Therapeutics and Revolution Medicines tested a combination of Tango's drug vopimetostat with Revolution's daraxonrasib in an early-stage clinical trial for pancreatic cancer. The study enroll…
- UnitedHealthcare reduces reimbursement for lactation counseling, sparking provider backlashUnitedHealthcare announced a change to its payment policy for lactation counseling services. The new policy would lower or eliminate reimbursement for many providers who offer these services, prom…